GeoPolitics Pulse

The Heartbeat of World events

Taiwan Bio, TRACT Therapeutics Complete TregCel Tech Transfer – Contract Pharma

by ·

Advances the companies’ efforts to prepare for a global Phase 2 trial in living donor kidney transplant patients. Taiwan Bio, TRACT Therapeutics …Read More

Related posts:

  1. Taiwan Bio Therapeutics and TRACT Therapeutics Announce Successful Transfer … – StreetInsider
  2. Taiwan Bio Therapeutics and TRACT Therapeutics Announce Successful Transfer … – Business Wire
  3. TRACT Transfers Its Regulatory T Cell Platform Technology to Taiwan Bio’s Manufacturing Facility
  4. Taiwan’s Biotech and Pharma Delegation: Innovations Take Center Stage at BIO 2024
  5. Outlook Therapeutics Streamlines Operations – FirstWord Pharma